Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuhang Shi

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Medcomm|December 18, 2025
Intranasal Mosaic H1N1 Live Attenuated Influenza Vaccine Elicits Broad Cross-Reactive Immunity and Protection Against Group 1 and 2 Influenza A VirusesXimeng Ma, Qi Chen, Yukun Cai, et al.
Emerging Microbes & Infections|July 4, 2020
Profiles of COVID-19 clinical trials in the Chinese Clinical Trial RegistryPeng Xu, Xiangyu Xing, Keying Yu, et al.
Emerging Microbes & Infections|October 16, 2025
Development of a broad-spectrum nasal live attenuated influenza vaccine based on mosaic antigen design against influenza B virusesXue Han, Run Ma, Ximeng Ma, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2025
Fully automated volumetric assessment of tumor burden using artificial intelligence on <sup>68</sup>Ga-PSMA-11 PET predicts survival after <sup>177</sup>Lu-PSMA therapy in metastatic Castration-resistant prostate cancerShiming Zang, Qingle Meng, Xiaoyuan Li, et al.
Journal of Ethnopharmacology|March 1, 2025
Tenghuang Jiangu tablet in knee osteoarthritis therapy: A prospective multicenter registry study in ChinaZelu Zheng, Xiaohan Wang, Baohong Mi, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Medcomm|December 18, 2025
Intranasal Mosaic H1N1 Live Attenuated Influenza Vaccine Elicits Broad Cross-Reactive Immunity and Protection Against Group 1 and 2 Influenza A VirusesXimeng Ma, Qi Chen, Yukun Cai, et al.
Emerging Microbes & Infections|July 4, 2020
Profiles of COVID-19 clinical trials in the Chinese Clinical Trial RegistryPeng Xu, Xiangyu Xing, Keying Yu, et al.
Emerging Microbes & Infections|October 16, 2025
Development of a broad-spectrum nasal live attenuated influenza vaccine based on mosaic antigen design against influenza B virusesXue Han, Run Ma, Ximeng Ma, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2025
Fully automated volumetric assessment of tumor burden using artificial intelligence on <sup>68</sup>Ga-PSMA-11 PET predicts survival after <sup>177</sup>Lu-PSMA therapy in metastatic Castration-resistant prostate cancerShiming Zang, Qingle Meng, Xiaoyuan Li, et al.
Journal of Ethnopharmacology|March 1, 2025
Tenghuang Jiangu tablet in knee osteoarthritis therapy: A prospective multicenter registry study in ChinaZelu Zheng, Xiaohan Wang, Baohong Mi, et al.
Pageof 4